A Novel Cuprotosis-Related Gene FDX1 Signature for Overall Survival Prediction in Clear Cell Renal Cell Carcinoma Patients

Table 3

Relationships between FDX1 expression and clinicopathological parameters in ccRCC.

Clinicopathological parameters	FDX1 expression
	High	Low	Total	value
Gender				0.045
Male	183 (53.2%)	161 (46.8%)	344
Female	82 (44.1%)	104 (55.9%)	186
Age				0.422
<60 years	124 (50.6%)	121 (49.4%)	245
>60 years	138 (51.9%)	128 (48.1%)	266
TNM				0.015
I-II stage	174 (54.0%)	148 (46.0%)	322
III-IV stage	90 (43.9%)	115 (56.1%)	205
Tumor				0.025
T1	147 (54.2%)	124 (45.8%)	271
T3	76 (44.2%)	96 (55.8%)	172
Lymph node metastasis				0.008
Negative	125 (52.3%)	114 (47.7%)	239
Positive	3 (18.8%)	13 (81.3%)	16
Distant metastasis				0.085
Negative	227 (51.6%)	213 (48.8%)	440
Positive	34 (42.5%)	46 (57.5%)	80
Grade				0.005
I-II	136 (56.4%)	105 (43.6%)	241
III-IV	126 (44.8%)	155 (55.2%)	281